Telemedicine for Prescribing Nirmatrelvir/Ritonavir: Safety, Logistics, and Challengesarticle Published on 2024-07-142024-09-05 Journal: Open Forum Infectious Diseases [Category] update2024, [키워드] COVID-19 Drug interactions interdisciplinary team Paxlovid Telemedicine [DOI] 10.1093/ofid/ofae283 PMC 바로가기 [Article Type] article
The therapeutic landscape for COVID-19 and post-COVID-19 medications from genetic profiling of the Vietnamese population and a predictive model of drug-drug interaction for comorbid COVID-19 patientsCorrespondence Published on 2024-03-052024-09-05 Journal: Heliyon [Category] update2024, [키워드] Chronic diseases COVID-19 drugs Drug interactions pharmacogenomics Post-COVID-19 drugs Vietnamese population [DOI] 10.1016/j.heliyon.2024.e27043 PMC 바로가기 [Article Type] Correspondence
Achillea millefolium : Mechanism of action, pharmacokinetic, clinical drug-drug interactions and tolerabilityReview Article Published on 2023-11-302024-09-05 Journal: Heliyon [Category] update2024, [키워드] Achillea millefolium Drug interactions mechanism of action Pharmacodynamics pharmacokinetics Toxicity [DOI] 10.1016/j.heliyon.2023.e22841 PMC 바로가기 [Article Type] Review Article
Pharmacokinetic interaction between verapamil and ritonavir-boosted nirmatrelvir: implications for the management of COVID-19 in patients with hypertensionarticle Published on 2023-01-132024-09-05 Journal: BMJ case reports [Category] update2024, [키워드] Arrhythmias COVID-19 Drug interactions [DOI] 10.1136/bcr-2022-252677 PMC 바로가기 [Article Type] article
An EUA for anakinra (Kineret) for COVID-19Article Published on 2022-12-122023-07-11 Journal: The Medical letter on drugs and therapeutics [Category] COVID19(2023년), [키워드] actemra adverse effects Anakinra Baricitinib Corticosteroids COVID-19 Dexamethasone dosage Drug interactions Efficacy lactation Olumiant Pregnancy Remdesivir Safety Tocilizumab Veklury
“Misstatements in Artemisinin-Based Combination Therapies in Malaria Treatment” by Fleckenstein and Millerarticle Published on 2022-10-312024-09-01 Journal: Dent Cadmos [Category] 말라리아, [키워드] Act CYP enzymes Drug interactions malaria P falciparum [Article Type] article
Interactions of the protease inhibitor, ritonavir, with common anesthesia drugsArticle Published on 2022-10-012022-11-15 Journal: Paediatric anaesthesia [Category] 치료제, [키워드] administration adverse effect affected Altered Anesthesia Antiviral antiviral drug approach Bioavailability change changes in children clearance Combination Comorbidities Concentration COVID-19 dependent on drug drug clearance drug dose Drug interactions early treatment enzyme example fentanyl increase in inhibited inhibitor inhibitory intrinsic management metabolic pathways pathway Patient Pharmacodynamics pharmacokinetic plasma concentration propofol Protease inhibitor remifentanil responsible Ritonavir subject Variability [DOI] 10.1111/pan.14529 PMC 바로가기
Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences위험, 약리학 그룹 및 결과에 따라 분류된 Paxlovid 팩트 시트에 나열된 상호 작용Article Published on 2022-08-012022-09-11 Journal: Revista española de quimioterapia : publicación [Category] COVID19(2023년), SARS, 치료제, [키워드] Administered Antiviral consequence COVID-19 CYP3A4 drug Drug interactions ELLA English force groups inhibitor Isoenzyme low dose medication Medicine Medicines metabolism Nirmatrelvir oxidative Paxlovid pharmacological Precaution precautions Prophylaxis protease responsible Ritonavir SARS-CoV-2 SARS-CoV-2 main protease Spanish therapeutic therapeutic effect Treatment [DOI] 10.37201/req/054.2022 PMC 바로가기 [Article Type] Article
Repurposing drugs as COVID-19 therapies: A toxicity evaluationCOVID-19 치료제로 약물 용도 변경: 독성 평가Review Published on 2022-07-012022-09-11 Journal: Drug discovery today [Category] COVID19(2023년), SARS, 신약개발, 치료제, [키워드] analyzed anti-SARS-CoV-2 Anti-SARS-CoV-2 Activity approved autophagy blockers chemical structures clinical trials contributed correlated COVID-19 CPE Cytopathic effect cytotoxicity database drug drug candidate drug candidates Drug interactions Drug repurposing Efficiency enrolled ether hERG High-throughput screening highlight house identify In vitro assay induce nonspecific pandemic Phospholipidosis profile repurposing SARS-CoV-2 Severe acute respiratory syndrome significantly Structure Toxicity [DOI] 10.1016/j.drudis.2022.04.001 PMC 바로가기 [Article Type] Review
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens Research Published on 2022-06-302022-10-05 Journal: NPJ Digital Medicine [Category] 신약개발, 임상, 치료법, 치료제, [키워드] adjusted B.1.351 B.1.617.2 Beta candidate drug clinically clinician combination regimen combination therapy combinations Community COVID-19 Delta drug combination Drug interactions Efficacy EIDD-1931 experimental validation Infectious disease Live virus pandemic platform Rapid regimen representing SARS-CoV-2 SARS-CoV-2 variant therapy translation Vero E6 was used [DOI] 10.1038/s41746-022-00627-4 [Article Type] Research